Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current Assets:    
Cash $ 2,662,520 $ 6,970,110
Prepaid expenses and other current assets 708,377 1,958,280
Total Current Assets 3,370,897 8,928,390
Intangible assets, net 1,587,188 1,658,858
In-process research and development 9,063,000
Total Assets 4,958,085 19,650,248
Current Liabilities:    
Accounts payable 1,713,164 1,801,210
Accrued expenses 2,375,660 2,284,516
Loans payable - current portion 332,885 1,308,516
Derivative liabilities 5,605 75,381
Total Current Liabilities 4,806,844 5,657,782
Loans payable – noncurrent portion 22,216 31,189
Deferred tax liability 278,352 2,617,359
Total Liabilities 5,107,412 8,306,330
Commitments and contingencies
Stockholders’ (Deficit) Equity:    
Common stock, $0.0001 par value; 100,000,000 shares authorized; 6,738,456 and 3,746,906 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively 674 375
Additional paid-in capital 128,815,362 121,637,611
Accumulated other comprehensive income (2,848,811) (2,885,523)
Accumulated deficit (126,116,552) (107,408,545)
Total Stockholders’ (Deficit) Equity (149,327) 11,343,918
Total Liabilities and Stockholders’ (Deficit) Equity 4,958,085 19,650,248
Series A Preferred Stock    
Stockholders’ (Deficit) Equity:    
Preferred stock
Class C Preferred Stock    
Stockholders’ (Deficit) Equity:    
Preferred stock
Class K Preferred Stock    
Stockholders’ (Deficit) Equity:    
Preferred stock
Related Parties    
Current Liabilities:    
Accounts payable – related parties 51,227
Accrued expenses - related parties $ 328,303 $ 188,159